HealthMap

Melatonin and Breast Cancer Risk: An Acu-Cell Perspective

• The Hormonal Connection: Melatonin, primarily known as a sleep-regulating hormone produced by the pineal gland, also plays a crucial role as a potent antioxidant and a regulator of endocrine function.
• Estrogen Regulation: Low levels of melatonin can indirectly contribute to an increased risk of hormone-sensitive cancers, including breast cancer, because melatonin helps modulate and suppress excessive estrogen production and receptor activity.
• Circadian Disruption: Shift work, chronic sleep deprivation, and exposure to artificial light at night suppress the body's natural melatonin synthesis, which compromises immune surveillance and cellular repair mechanisms.
• Nutritional and Biochemical Factors:
• Proper melatonin synthesis depends on adequate availability of specific precursors and cofactors, such as tryptophan, vitamin B6, zinc, and magnesium.
• Deficiencies in these key nutrients can impair both sleep quality and the body's natural oncostatic (tumor-suppressing) defenses.
• Therapeutic Approach:
• Restoring optimal melatonin levels should involve addressing circadian hygiene, reducing nighttime light exposure, and correcting underlying nutritional deficiencies.
• In certain cases, targeted supplementation may be beneficial, but it must be balanced within a comprehensive nutritional and biochemical profile to support overall endocrine health.